Optibrium introduces StarDrop 5.4 to target novel, safe and efficacious drugs

Optibrium, a developer of software for drug discovery, todayannounced the release of version 5.4 of its StarDrop software platform. Itoffers enhanced features to guide the design of novel, safe and efficaciousdrugs by providing access to world-leading technologies for toxicity predictionand bioisosteric transformations. These new optional modules further extendStarDrop's capabilities to intuitively target high-quality compounds in drugdiscovery, reducing the time and cost to deliver drug candidates with animproved chance of success.